Does PEGCETACOPLAN Cause Off label use? 97 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 97 reports of Off label use have been filed in association with PEGCETACOPLAN (Empaveli). This represents 7.1% of all adverse event reports for PEGCETACOPLAN.
97
Reports of Off label use with PEGCETACOPLAN
7.1%
of all PEGCETACOPLAN reports
9
Deaths
35
Hospitalizations
How Dangerous Is Off label use From PEGCETACOPLAN?
Of the 97 reports, 9 (9.3%) resulted in death, 35 (36.1%) required hospitalization, and 3 (3.1%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEGCETACOPLAN. However, 97 reports have been filed with the FAERS database.
What Other Side Effects Does PEGCETACOPLAN Cause?
Fatigue (135)
Visual impairment (125)
Haemoglobin decreased (106)
Haemolysis (100)
Vitreous floaters (78)
Breakthrough haemolysis (67)
Headache (66)
Product dose omission issue (59)
Uveitis (59)
Covid-19 (56)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which PEGCETACOPLAN Alternatives Have Lower Off label use Risk?
PEGCETACOPLAN vs PEGFILGRASTIM
PEGCETACOPLAN vs PEGFILGRASTIM-APGF
PEGCETACOPLAN vs PEGFILGRASTIM-BMEZ
PEGCETACOPLAN vs PEGFILGRASTIM-CBQV
PEGCETACOPLAN vs PEGFILGRASTIM-JMDB